Cannalink, Inc. (OTCPK: CNLK)
Health Care · Pharmaceuticals · US
$—
— today · — 1Y
Cannalink, Inc. (OTCPK: CNLK) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $2.00K.
trading between 0.02 and 0.02.
CNLK price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $2.00K
- Revenue (TTM)
- —
- P/E
- —
- EPS
- —
- Dividend yield
- —
- Beta (5Y)
- 34.30
- 52-week high
- $0.02
- 52-week low
- $0.02
- Avg volume (3M)
- —
- Shares outstanding
- 100.00K
- Employees
- —
- Next earnings
- —
About Cannalink, Inc.
Headquartered in San Diego, California, Cannalink, Inc. is a company in its development phase. Its primary objectives include the creation of products derived from cannabidiol (CBD) and offering specialized support to nascent businesses operating within the medical marijuana and industrial healthcare sectors.
- ISIN
- US13765B1035
- Listed since
- Aug 25, 1998
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,239.69 | -1.25% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $271.54 | +0.48% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $149.86 | -1.76% |
| Roche Holding AGSWX: ROP | $373.91B | CHF369.10 | -1.73% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £120.32 | -1.70% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $27.88 | -0.68% |
Figures last refreshed Aug 18, 2026.